Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activity.
Agrawal NG, Matthews CZ, Mazenko RS, Woolf EJ, Porras AG, Chen X, Miller JL, Michiels N, Wehling M, Schultz A, Gottlieb AB, Kraft WK, Greenberg HE, Waldman SA, Curtis SP, Gottesdiener KM. Agrawal NG, et al. Among authors: greenberg he. J Clin Pharmacol. 2004 Oct;44(10):1125-31. doi: 10.1177/0091270004268129. J Clin Pharmacol. 2004. PMID: 15342613 Clinical Trial.
Effect of mibefradil on CYP3A4 in vivo.
Veronese ML, Gillen LP, Dorval EP, Hauck WW, Waldman SA, Greenberg HE. Veronese ML, et al. Among authors: greenberg he. J Clin Pharmacol. 2003 Oct;43(10):1091-100. doi: 10.1177/0091270003256687. J Clin Pharmacol. 2003. PMID: 14517191 Clinical Trial.
Indinavir and rifabutin drug interactions in healthy volunteers.
Kraft WK, McCrea JB, Winchell GA, Carides A, Lowry R, Woolf EJ, Kusma SE, Deutsch PJ, Greenberg HE, Waldman SA. Kraft WK, et al. Among authors: greenberg he. J Clin Pharmacol. 2004 Mar;44(3):305-13. doi: 10.1177/0091270003262807. J Clin Pharmacol. 2004. PMID: 14973305 Clinical Trial.
Pharmacokinetics of aprepitant after single and multiple oral doses in healthy volunteers.
Majumdar AK, Howard L, Goldberg MR, Hickey L, Constanzer M, Rothenberg PL, Crumley TM, Panebianco D, Bradstreet TE, Bergman AJ, Waldman SA, Greenberg HE, Butler K, Knops A, De Lepeleire I, Michiels N, Petty KJ. Majumdar AK, et al. Among authors: greenberg he. J Clin Pharmacol. 2006 Mar;46(3):291-300. doi: 10.1177/0091270005283467. J Clin Pharmacol. 2006. PMID: 16490805 Clinical Trial.
Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects.
Bergman AJ, Burke J, Larson P, Johnson-Levonas AO, Reyderman L, Statkevich P, Kosoglou T, Greenberg HE, Kraft WK, Frick G, Murphy G, Gottesdiener K, Paolini JF. Bergman AJ, et al. Among authors: greenberg he. J Clin Pharmacol. 2006 Mar;46(3):321-7. doi: 10.1177/0091270005284851. J Clin Pharmacol. 2006. PMID: 16490808 Clinical Trial.
Effect of aprepitant on the pharmacokinetics of intravenous midazolam.
Majumdar AK, Yan KX, Selverian DV, Barlas S, Constanzer M, Dru J, McCrea JB, Ahmed T, Frick GS, Kraft WK, Petty KJ, Greenberg HE. Majumdar AK, et al. Among authors: greenberg he. J Clin Pharmacol. 2007 Jun;47(6):744-50. doi: 10.1177/0091270007300807. Epub 2007 Apr 26. J Clin Pharmacol. 2007. PMID: 17463213 Clinical Trial.
Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant.
Stoch SA, Gargano C, Valentine J, Braun MP, Murphy MG, Fedgchin M, Majumdar A, Pequignot E, Gottesdiener KM, Petty KJ, Panebianco D, Dean D, Kraft WK, Greenberg HE. Stoch SA, et al. Among authors: greenberg he. Cancer Chemother Pharmacol. 2011 Jun;67(6):1313-21. doi: 10.1007/s00280-010-1421-y. Epub 2010 Aug 24. Cancer Chemother Pharmacol. 2011. PMID: 20734049 Clinical Trial.
Characterization of etoricoxib, a novel, selective COX-2 inhibitor.
Dallob A, Hawkey CJ, Greenberg H, Wight N, De Schepper P, Waldman S, Wong P, DeTora L, Gertz B, Agrawal N, Wagner J, Gottesdiener K. Dallob A, et al. J Clin Pharmacol. 2003 Jun;43(6):573-85. J Clin Pharmacol. 2003. PMID: 12817520 Clinical Trial.
73 results